Diagnostic and Interventional Cardiology

Keyur Vora, MD, MS, George Revtyak, MD, and Rohan Dharmakumar, PhD with the first patient to enroll in a new cardiovascular clinical trial.

First Patient Enrolls in IU-led Clinical Trial to Study Treatment for Acute Heart Attack Complications

December 27, 2022 — A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients ...

December 27, 2022

Two-day educational symposium was held in New York City at the NBPA’s headquarters

News | Cardiovascular Education

Morristown Medical Center’s Matthew Martinez, MD Held First Sports Cardiology Summit for Elite and Professional Athletes

December 26, 2022 — Cardiologists, team physicians, certified athletic trainers, advanced practice providers, fellows ...

December 26, 2022

Limited Exclusion Order would bar Apple from importing infringing Apple Watches

News | ECG

ITC Rules Apple Violated AliveCor’s Patents

December 26, 2022 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...

December 26, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

News | Diagnostic and Interventional Cardiology DAIC

Happy Holidays from DAIC

December 25, 2022 — The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and ...

December 25, 2022

According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be valued at $2,897.2 million in 2022 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2022-2030).

News | Stents Drug Eluting

Global Drug Eluting Stents Market to Surpass US$ 4,844.6 Million by 2030, Says Coherent Market Insights

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

December 23, 2022

The first of its kind study involved 60 patients and confirmed Electroducer Sleeve as a safe and effective treatment for heart diseases

News | Guidewires

Electroducer announces the publication of positive results from its pilot study in EuroIntervention medical journal

December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment ...

December 23, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.

News | Cardiovascular Business

Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...

December 22, 2022

Individuals with coronary artery disease exist on a spectrum of disease, such as the amount of plaque build-up in the arteries of the heart; however, the disease is conventionally classified as broad categories of case (yes disease) or control (no disease), which may result in misdiagnosis. A digital marker for coronary artery disease derived from machine learning and electronic health records can better quantify where an individual falls on the disease spectrum. Credit: Icahn School of Medicine at Mount Si

News | Heart Failure

Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn ...

December 22, 2022

The AcQCross Qx system combines the dilator and needle needed to perform left-atrial appendage closure procedures, eliminating the need to swap equipment mid-surgery while crossing into the left side of the heart. (Pixabay)

News | Left Atrial Appendage (LAA) Occluders

Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

December 22, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Collaborative team from Rockefeller University, Cleveland Clinic publish findings in Science

News | Coronavirus (COVID-19)

Research Identifies Potential Genetic Cause for MIS-C Complication Following COVID-19 Infection

December 22, 2022 — New research findings have revealed an underlying genetic cause for why some children who have had ...

December 22, 2022

Robbin Cohen, MD, now serves as director of the Cardiac Surgery Program at Huntington Health, a Cedars-Sinai affiliate, and will be practicing out of Huntington Health’s Pasadena campus.

News | Cardiovascular Surgery

Cedars-Sinai Expands Cardiac Surgery at Huntington Health

December 21, 2022 — The Smidt Heart Institute at Cedars-Sinai is again expanding its geographic reach and surgical ...

December 21, 2022

The Arrhythmia Care Team at Corewell Health Celebrate First Successful Procedures With New Genesis Robotic Cardiac Ablation System from Stereotaxis.

News

Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

December 21, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint

News | Cardiovascular Clinical Studies

CLEAR Outcomes Accepted as Late-Breaking Clinical Trial at ACC.23 Annual Scientific Session & Expo together with the World Congress of Cardiology

December 21, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

December 21, 2022

Arrow International, LLC, a Subsidiary of Teleflex, Inc, recalls Arrow AutoCAT 2, AC3 intra-aortic balloon pumps for unexpectedly short battery run times

Feature | Intra-Aortic Balloon Pumps (IABP)

Teleflex Recalls Arrow Intra-Aortic Balloon Pumps for Short Battery

The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic ...

December 20, 2022

Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.23/WCC) have been announced.

Feature | ACC | By Melinda Taschetta-Millane

ACC 2023 Late-breaking Clinical Trials Announced

Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World ...

December 20, 2022